ArticleNPJ breast cancer2025

Real-world effectiveness of palbociclib plus an aromatase inhibitor in HR+/HER2- MBC patients living in disadvantaged neighborhoods.

Filipa Lynce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.